Suppr超能文献

PharmGKB summary: oxycodone pathway, pharmacokinetics.

作者信息

Huddart Rachel, Clarke Melissa, Altman Russ B, Klein Teri E

机构信息

Departments of Biomedical Data Sciences.

Medical Home Development Group, Washington, District of Columbia.

出版信息

Pharmacogenet Genomics. 2018 Oct;28(10):230-237. doi: 10.1097/FPC.0000000000000351.

Abstract
摘要

相似文献

1
PharmGKB summary: oxycodone pathway, pharmacokinetics.
Pharmacogenet Genomics. 2018 Oct;28(10):230-237. doi: 10.1097/FPC.0000000000000351.
3
The pharmacokinetics of oxycodone.
J Pain Palliat Care Pharmacother. 2004;18(4):17-30. doi: 10.1300/j354v18n04_03.
5
Sex differences in the pharmacokinetics, oxidative metabolism and oral bioavailability of oxycodone in the Sprague-Dawley rat.
Clin Exp Pharmacol Physiol. 2008 Mar;35(3):295-302. doi: 10.1111/j.1440-1681.2007.04821.x. Epub 2007 Oct 31.
7
[The blood-brain barrier transport mechanism controlling analgesic effects of opioid drugs in CNS].
Yakugaku Zasshi. 2015;135(5):697-702. doi: 10.1248/yakushi.14-00234-2.
8
Gender difference in prescription opioid abuse: A focus on oxycodone and hydrocodone.
Pharmacol Res. 2016 Jun;108:31-38. doi: 10.1016/j.phrs.2016.04.012. Epub 2016 Apr 20.
10
Population pharmacokinetics of oxycodone in patients with cancer-related pain.
J Pain Palliat Care Pharmacother. 2012 Sep;26(3):220-5. doi: 10.3109/15360288.2012.702200.

引用本文的文献

1
Persistent Transcriptome Alterations in Zebrafish Embryos After Discontinued Opioid Exposure.
Int J Mol Sci. 2025 May 19;26(10):4840. doi: 10.3390/ijms26104840.
2
Brain Cytochrome P450: Navigating Neurological Health and Metabolic Regulation.
J Xenobiot. 2025 Mar 14;15(2):44. doi: 10.3390/jox15020044.
3
Do CYP2D6 genotypes affect oxycodone dose, pharmacokinetics, pain, and adverse effects in cancer?
Pharmacogenomics. 2024;25(14-15):579-586. doi: 10.1080/14622416.2024.2430161. Epub 2024 Dec 4.
4
Opioid-positive urine drug screen during treatment with oral naltrexone and the clinical implications.
Ment Health Clin. 2024 Apr 1;14(2):102-106. doi: 10.9740/mhc.2024.04.102. eCollection 2024 Apr.
5
Effects of pharmacogenetic profiles on pediatric pain relief and adverse events with ibuprofen and oxycodone.
Pain Rep. 2023 Oct 17;8(6):e1113. doi: 10.1097/PR9.0000000000001113. eCollection 2023 Dec.
7
Hydrocodone, Oxycodone, and Morphine Metabolism and Drug-Drug Interactions.
J Pharmacol Exp Ther. 2023 Nov;387(2):150-169. doi: 10.1124/jpet.123.001651. Epub 2023 Sep 7.
8
The Pharmacological Treatment of Chronic Pain: From Guidelines to Daily Clinical Practice.
Pharmaceutics. 2023 Apr 6;15(4):1165. doi: 10.3390/pharmaceutics15041165.
10
Assessment of Neurotoxic Effects of Oxycodone and Naloxone in SH-SY5Y Cell Line.
Int J Mol Sci. 2023 Jan 11;24(2):1424. doi: 10.3390/ijms24021424.

本文引用的文献

1
The impact of UGT2B7 C802T and CYP3A4*1G polymorphisms on pain relief in cancer patients receiving oxycontin.
Support Care Cancer. 2018 Aug;26(8):2763-2767. doi: 10.1007/s00520-018-4130-4. Epub 2018 Mar 3.
2
Oxycodone Resistance Due to Rifampin Use in an Osteosarcoma Patient with Tuberculosis.
Am J Case Rep. 2017 Oct 24;18:1130-1134. doi: 10.12659/ajcr.905637.
4
Oxycodone for cancer-related pain.
Cochrane Database Syst Rev. 2017 Aug 22;8(8):CD003870. doi: 10.1002/14651858.CD003870.pub6.
6
CYP2D6 pharmacogenetic and oxycodone pharmacokinetic association study in pediatric surgical patients.
Pharmacogenomics. 2017 Mar;18(4):337-348. doi: 10.2217/pgs-2016-0183. Epub 2017 Feb 17.
7
African Genetic Diversity: Implications for Cytochrome P450-mediated Drug Metabolism and Drug Development.
EBioMedicine. 2017 Mar;17:67-74. doi: 10.1016/j.ebiom.2017.02.017. Epub 2017 Feb 20.
8
Maturation of Oxycodone Pharmacokinetics in Neonates and Infants: a Population Pharmacokinetic Model of Three Clinical Trials.
Pharm Res. 2017 May;34(5):1125-1133. doi: 10.1007/s11095-017-2122-6. Epub 2017 Feb 15.
9
Maturation of oxycodone pharmacokinetics in neonates and infants: Oxycodone and its metabolites in plasma and urine.
Br J Clin Pharmacol. 2017 Apr;83(4):791-800. doi: 10.1111/bcp.13164. Epub 2016 Dec 5.
10
Characterization of oxycodone in vitro metabolism by human cytochromes P450 and UDP-glucuronosyltransferases.
J Pharm Biomed Anal. 2017 Sep 10;144:129-137. doi: 10.1016/j.jpba.2016.09.024. Epub 2016 Sep 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验